Abstract:This study identified common dysregulated genes and pathways in aging and cancer, revealing tissue‐specific age‐associated gene expression and cellular processes. Using an AI‐driven approach, we identified multiple novel dual‐purpose targets for cancer and aging treatment. Notably, we highlighted KDM1A as a promising dual‐purpose target, with our findings demonstrating lifespan extension in C. elegans and opening new avenues for therapeutic advancements. As aging and tumorigenesis are tightly interconnected biological processes, targeting their common underlying driving pathways may induce dual‐purpose anti‐aging and anti‐cancer effects. Our transcriptomic analyses of 16,740 healthy samples demonstrated tissue‐specific age‐associated gene expression, with most tumor suppressor genes downregulated during aging. Furthermore, a large‐scale pan‐cancer analysis of 11 solid tumor types (11,303 cases and 4431 control samples) revealed that many cellular processes, such as protein localization, DNA replication, DNA repair, cell cycle, and RNA metabolism, were upregulated in cancer but downregulated in healthy aging tissues, whereas pathways regulating cellular senescence were upregulated in both aging and cancer. Common cancer targets were identified by the AI‐driven target discovery platform—PandaOmics. Age‐associated cancer targets were selected and further classified into four groups based on their reported roles in lifespan. Among the 51 identified age‐associated cancer targets with anti‐aging experimental evidence, 22 were proposed as dual‐purpose targets for anti‐aging and anti‐cancer treatment with the same therapeutic direction. Among age‐associated cancer targets without known lifespan‐regulating activity, 23 genes were selected based on predicted dual‐purpose properties. Knockdown of histone demethylase KDM1A, one of these unexplored candidates, significantly extended lifespan in Caenorhabditis elegans. Given KDM1A's anti‐cancer activities reported in both preclinical and clinical studies, our findings propose KDM1A as a promising dual‐purpose target. This is the first study utilizing an innovative AI‐driven approach to identify dual‐purpose target candidates for anti‐aging and anti‐cancer treatment, supporting the value of AI‐assisted target identification for drug discovery.

An approach using Caenorhabditis elegans screening novel targets to suppress tumour cell proliferation.

Abstract 2389: LINC00901 Regulates Glucose Metabolism in Pancreatic Cancer

Linc00901 Regulates Glucose Metabolism In Pancreatic Cancer.

A Genome-Wide RNAi Screen for Enhancers of a Germline Tumor Phenotype Caused by Elevated GLP-1/Notch Signaling in Caenorhabditis elegans.

Dual Inhibiting Oct4 and Akt Potently Suppresses the Propagation of Human Cancer Cells

Quantitative proteomics analysis of Caenorhabditis elegans upon germ cell loss.

Germline Signaling Mediates the Synergistically Prolonged Longevity Produced by Double Mutations in Daf-2 and Rsks-1 in C. Elegans

LC–MS Proteomics Analysis of the Insulin/IGF-1-Deficient Caenorhabditis elegans daf-2(e1370) Mutant Reveals Extensive Restructuring of Intermediary Metabolism

Genetic Loss of Nrf1 and Nrf2 Leads to Distinct Metabolism Reprogramming of HepG2 Cells by Opposing Regulation of the PI3K-AKT-mTOR Signalling Pathway.

Towards Understanding the Lifespan Extension by Reduced Insulin Signaling: Bioinformatics Analysis of Daf-16/Foxo Direct Targets in Caenorhabditis Elegans

Intermediate metabolites of the pyrimidine metabolism pathway extend the lifespan of C. elegans through regulating reproductive signals

Kinome-wide RNAi screen in Caenorhabditis elegans reveals new modulators of insulin signaling and longevity

Long non-coding RNA-based glycolysis-targeted cancer therapy: feasibility, progression and limitations

Lycium barbarum glycopetide prolong lifespan and alleviate Parkinson's disease in Caenorhabditis elegans

Metabolomic Signature Associated with Reproduction-Regulated Aging in Caenorhabditis Elegans.

IDDF2018-ABS-0184 LNCRNA AGPG Regulates Anabolism Remodelling Through Affecting PFKFB3 Stability in Escc

Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans

A comprehensive AI‐driven analysis of large‐scale omic datasets reveals novel dual‐purpose targets for the treatment of cancer and aging

Tumour Cell Dormancy As A Contributor To The Reduced Survival Of Gbm Patients Who Received Standard Therapy

Pioglitazone Hydrochloride Extends the Lifespan of Caenorhabditis elegans by Activating DAF-16/FOXO- and SKN-1/NRF2-Related Signaling Pathways

Knockdown of phosphatases of regenerating liver-1 prolongs the lifespan of Caenorhabditis elegans via activating DAF-16/FOXO